Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1107 | 1108 | (Page 1109) | 1110 | 1111 | .... | 1118 | newer

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 06, 2018 ) Rising health awareness has driven adoption of personalized medicines and home diagnostics among consumers. Sensing the requirements of end-users, home diagnostics market players are focusing on enhancing efficiency, accuracy, reliability, and convenience. The investments have invariably shifted to incorporation of advanced technology in the manufacture of home diagnostics. Through adoption of wearable technologies, Internet of Things (IoT), and Artificial Intelligence (AI), market players are working on enhancing the performance features of home diagnostics. For instance, Siemens Healthcare and Abbott Technologies, are introducing various types of digital home diagnostics that can be integrated with smartphones, which may become an emerging market trend in the upcoming years.

    Get a free sample copy of home diagnostics market Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

    Low Penetration of Home Diagnostics in Emerging Markets: A Longstanding Challenge

    Developed countries are witnessing rising adoption of advanced technologies to develop highly-efficient home diagnostics with the increasing focus on R&D Consumers are becoming more aware of the availability of home diagnostics that can enable them to conduct in vitro diagnosis tests at home without the need for any professional assistance. However, lower health awareness in developing nations, especially in Asia and the Middle East & Africa, is restricting the adoption of home diagnostics. Despite the larger consumer base and growing number of deaths caused due to chronic diseases, penetration of home diagnostics remains low in emerging markets. Leading manufacturers in the Home Diagnostics Market are modifying their marketing strategies to scale up their presence in developing nations and boost regional economic growth in the upcoming years.

    Home Diagnostics Continues to be a Heavily Regulated Industry

    As home diagnostics help patients to detect diseases without any professional medical assistance, the accuracy and precision of the results provided by these tests plays an important role in the performance of home diagnostics. Taking into consideration the pervasiveness of home diagnostics, governing organizations across the world are imposing stringent rules and regulations to ensure the quality and reliability of home diagnostics marketed worldwide. Home diagnostics manufacturers need to comply with Section 510(k) of the Food, Drug and Cosmetic Act and get Premarket Approval Application (PMA) approvals established by FDA to enter the US home diagnostics market. In addition, the European Union has imposed regulations, such as Medical Devices Regulation 2017/745/EU and In Vitro Diagnostic Medical Devices Regulation 2017/746/EU that all the stakeholders in the home diagnostics market need to comply with. Strict quality control regulations and labeling requirements may influence growth prospects of the home diagnostics market, as they may make it difficult for market players to reduce manufacturing costs.

    Browse complete details about Home Diagnostics Market Report: https://www.factmr.com/report/1892/home-diagnostics-market

    Rising Incidences of Diabetes and Other Lifestyle Diseases Fueling Demand for Home Diagnostic Solutions

    The number of patients suffering from diabetes across the world has increased from 108 million in 1980 to around 422 million in 2014, which the World Health Organization (WHO) predicts to become a leading cause of death by 2030. Anticipating the rapidly increasing prevalence of diabetes, leading manufacturers in the home diagnostics market are adopting strategies to provide glucose monitoring devices, which may witness higher demand in the coming future. Further, the number of Americans suffering from hearing loss has doubled in last fifteen years, which is encouraging stakeholders in the home diagnostics market to introduce hearing assessment kits. Keeping a close look at dynamic prevalence of various health conditions is helping home diagnostics manufacturers to discover useful insights, which are enabling them to plan appropriate business strategies in the near future.

    Initiatives by International Organizations to Promote Health Awareness Likely to Boost Adoption of Home Diagnostics

    Alarming rise in the number of incidences of lifestyle diseases and deaths causes due to chronic health disorders is influencing health organizations and governing bodies to shift their focus on improving the quality of diagnostic services. As stated by the WHO that “an accurate diagnosis is the first step to getting effective treatment,” awareness about the importance of home diagnostics is increasing among governing bodies. The WHO recently released the Essential Diagnostics List, which recognizes home diagnostics as a vital element to improve global health coverage. As enhancing the quality of diagnosis is one of the priorities of the WHO Thirteenth General Programme of Work (2019–2023) (GPW), the initiates taken by the organization may help stakeholders in the home diagnostics market to boost ales in the upcoming years.

    Competitive Analysis

    The Fact.MR report helps readers to track the salient developments in strategies adopted by their competitors in the home diagnostics market and plan their upcoming strategies accordingly. The report covers all the leading stakeholders in the home diagnostics market and provides detailed information including the company revenues as well as their business plans for the coming future. Market players in the home diagnostics market that are featured in the report include Abbott Laboratories, ACON Laboratories Inc., BTNX Inc., ARKRAY Inc., Assure Tech (Hangzhou) co. Ltd., Becton Dickinson & Company, Bionime Corporation, Roche Holding AG, Quidel Corporation, and True Diagnostics Inc.

    Leading market players in the home diagnostics market are adopting collaborative strategies to scale up their presence in the highly competitive environment in the global diagnostics industry. For example, in order to expand its innovative diagnostics portfolio, Quidel Corportation recently acquired Alere Triage® assets including its cardiovascular & toxicology business and B-type Naturietic Peptide (BNP) assay business. Another leading stakeholder in the home diagnostics market – Roche Holding AG entered into a strategic partnership with GE Healthcare to deliver in-vivo and in-vitro data-driven diagnostics, which include tests that critical care patients can use at home.

    For any query get connect with an Analyst: https://www.factmr.com/connectus/sample?flag=AE&rep_id=1892

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) “Global Raltegravir Market Analysis, Segmentation, Key Players, Future Outlook 2023”, is valuable report recently incorporated in most updated data base of Qurate Business Intelligence which aims to examine the entire worldwide market with great interest, analytical approach and holistic perspective. It offers comprehensive evaluation of the global market supported by statistical data as well as insightful information. Projections associated with the market values over the estimated period are built through pragmatic research and numerical data collected through both primary and secondary sources. The trustworthy processes followed to include various features of the market makes the data sound in context to time as well as market.

    Request for Free Sample Copy of This Report: https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-119007

    This study is tremendously useful textual document with inclusion of extensive market data in relation with the remarkable rudiments and subdivision of the “Global Raltegravir Market” that are likely to impact the growth circumstances of the industry. The study may splendidly assist professionals and decision makers to address the glitches and to gain help from highly competitive “Global Raltegravir Market”.
    “Global Raltegravir Market” is research report which entails statistics associated with vital regional markets and current scenarios. This enlists key regional areas such as North America, Europe, Asia-Pacific, etc. and the prime countries such as United States, Germany, United Kingdom, Japan, South Korea and China.

    Enquiry Before Buying@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-119007

    The “Global Raltegravir Market” report attempts to shape knowledge of the market through delivery of data associated with features such as classifications, applications and market overview, product specifications, manufacturing processes, cost structures, raw materials and more. Furthermore, it strives to inspect the key regional markets, including constraints such as product price, profit, capacity, production, supply, demand and market growth rate. It also converses forecast for the same. The report concludes with new project SWOT analysis, investment feasibility analysis, and investment return analysis.

    Further, this assessment distinguishes pin-point analysis of competitive landscape and assists readers to create an edge over competitors. It delivers a noteworthy data and understandings associated with factors driving or preventing the growth of the market. It brings a nine-year forecast evaluated based on how the market is anticipated to perform.

    Get 30 % discount on this report: https://www.qurateresearch.com/report/discount/HnM/QBI-LPI-HnM-119007

    It supports professionals, teams and organizations, in understanding the key current market scenarios and expected future growth as well. Its assistance in taking informed corporate decisions by sharing comprehensive perceptions of the market and by creating an in-depth analysis of market elements of greater significance. To summaries, it also offers composed graphics and modified SWOT analysis of important market elements.

    This report enlists in-depth analysis of the worldwide market for “Raltegravir Market”, talking about various market components such as the production capacity, product pricing, the dynamics of demand and supply, sales volume, revenue, growth rate and more.

    Purchase Complete Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-119007/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) “Global Pneumococcal Vaccine Polyvalent Market Analysis, Segmentation, Key Players, Future Outlook 2023”, is valuable report recently incorporated in most updated data base of Qurate Business Intelligence which aims to examine the entire worldwide market with great interest, analytical approach and holistic perspective. It offers comprehensive evaluation of the global market supported by statistical data as well as insightful information. Projections associated with the market values over the estimated period are built through pragmatic research and numerical data collected through both primary and secondary sources. The trustworthy processes followed to include various features of the market makes the data sound in context to time as well as market.

    Request for Free Sample Copy of This Report: https://www.qurateresearch.com/report/sample/HnM/QBI-LPI-HnM-119008

    This study is tremendously useful textual document with inclusion of extensive market data in relation with the remarkable rudiments and subdivision of the “Global Pneumococcal Vaccine Polyvalent Market” that are likely to impact the growth circumstances of the industry. The study may splendidly assist professionals and decision makers to address the glitches and to gain help from highly competitive “Global Pneumococcal Vaccine Polyvalent Market”.
    “Global Pneumococcal Vaccine Polyvalent Market” is research report which entails statistics associated with vital regional markets and current scenarios. This enlists key regional areas such as North America, Europe, Asia-Pacific, etc. and the prime countries such as United States, Germany, United Kingdom, Japan, South Korea and China.

    Enquiry Before Buying@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-LPI-HnM-119008

    The “Global Pneumococcal Vaccine Polyvalent Market” report attempts to shape knowledge of the market through delivery of data associated with features such as classifications, applications and market overview, product specifications, manufacturing processes, cost structures, raw materials and more. Furthermore, it strives to inspect the key regional markets, including constraints such as product price, profit, capacity, production, supply, demand and market growth rate. It also converses forecast for the same. The report concludes with new project SWOT analysis, investment feasibility analysis, and investment return analysis.

    Further, this assessment distinguishes pin-point analysis of competitive landscape and assists readers to create an edge over competitors. It delivers a noteworthy data and understandings associated with factors driving or preventing the growth of the market. It brings a nine-year forecast evaluated based on how the market is anticipated to perform.

    Get 30 % discount on this report: https://www.qurateresearch.com/report/discount/HnM/QBI-LPI-HnM-119008

    It supports professionals, teams and organizations, in understanding the key current market scenarios and expected future growth as well. Its assistance in taking informed corporate decisions by sharing comprehensive perceptions of the market and by creating an in-depth analysis of market elements of greater significance. To summaries, it also offers composed graphics and modified SWOT analysis of important market elements.

    This report enlists in-depth analysis of the worldwide market for “Pneumococcal Vaccine Polyvalent Market”, talking about various market components such as the production capacity, product pricing, the dynamics of demand and supply, sales volume, revenue, growth rate and more.

    Purchase Complete Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-LPI-HnM-119008/


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) The United Kingdom (U.K.) stands next to the United States of America (U.S.A.) in coming up with latest technologies to combat the spread of cancer. The cancer screening market in the U.K. is expected to reach USD Bn by 2023 at a CAGR of 8.5%.
    Cancer screening market in the U.K. is classified by end users, screening type, and applications. By end users, it is further classified into hospitals, laboratories and independent physicians and clinics. By screening type, it is classified into laboratory, genetic, biopsy, imaging and endoscopy testing. By application type, it is further classified into lung, breast, melanoma, kidney and colorectal type.

    Request for Free Sample@ https://www.qurateresearch.com/report/sample/HnM/QBI-NTS-HnM-60955

    Key growth factors

    Increasing prevalence of cancer, funded initiatives from the government side and the growing trend to follow a sedentary lifestyle are the key growth factors in this region.

    Threats and key players

    The complicated regulatory framework has the potential to halt the growth of the market. The exorbitant cost of the services and medicinal methodologies can cease he growth of the market.
    The key players operating in the valve market are Abbott Healthcare, Agilent, Becton Dickinson, Biomedical Diagnostics, Qiagen, Thermo Fisher Scientific and Bio-Rad.

    Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-NTS-HnM-60955

    What is covered in the report?

    1. Overview of the cancer screening market in the U.K.
    2. Market drivers and challenges in the cancer screening market in the U.K.
    3. Market trends in the cancer screening market in the U.K.
    4. Historical, current and forecasted market size data for segments based on end users (hospitals, laboratories and independent physicians and clinics).
    5. Historical, current and forecasted market size data for segments based on screening type (laboratory, genetic, biopsy, imaging and endoscopy testing).
    6. Historical, current and forecasted market size data for segmentation based on application type (lung, breast, melanoma, kidney and colorectal cancer).
    7. Analysis of the competitive landscape and profiles of the major companies operating in the market.

    Click on the link to Buy Now@ https://www.qurateresearch.com/report/buy/HnM/QBI-NTS-HnM-60955

    Why buy?

    o Understand the demand for cancer screening market in the U.K. to determine the viability of the market.
    o Identify the developed and emerging markets where cancer screening market in the U.K. are sold.
    o Identify the challenge areas and address them.
    o Develop strategies based on the drivers, trends and highlights for each of the segments.
    o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
    o Recognize the key competitors of this market and respond accordingly.
    o Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.
    o Define the competitive positioning by comparing the products and services with the key players in the market.


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) The United States of America (U.S.A.) is leading the cancer screening market. The rising incidence of cancer along with growing awareness regarding prevention of diseases and diagnosis is a key driver for the market. There is increased technological advancement along with fund based initiatives towards research and development (R&D) for awareness and prevention of diseases. The cancer screening market is expected to reach USD 13.12 Bn by 2023 growing at a CAGR of 10.95%.

    Request for Free Sample@ https://www.qurateresearch.com/report/sample/HnM/QBI-NTS-HnM-60956

    Cancer screening market in the U.S.A. is classified by end users, screening type, and applications. By end users, it is further classified into hospitals, laboratories and independent physicians and clinics. By screening type, it is classified into laboratory, genetic, biopsy, imaging and endoscopy testing. By application type, it is further classified into lung, breast, melanoma, kidney and colorectal cancer.

    Key growth factors

    Increasing prevalence of cancer, funded initiatives from the government side and the growing trend to follow a sedentary lifestyle are the key growth factors for the region.

    Threats and key players

    Growing inter and intrastate barriers along with complicated frameworks has the potential to halt the growth of the market.
    The key players operating in the U.S.A. cancer screening market are Roche Diagnostics, Abbott Laboratories, GE Healthcare Qiagen, Thermo Fisher Scientific and Siemens Healthineers

    Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-NTS-HnM-60956

    What is covered in the report?

    1. Overview of the cancer screening market in the U.S.A.
    2. Market drivers and challenges in the cancer screening market in the U.S.A.
    3. Market trends in the cancer screening market in the U.S.A.
    4. Historical, current and forecasted market size data for segments based on end users (hospitals, laboratories and independent physicians and clinics).
    5. Historical, current and forecasted market size data for segments based on screening type (laboratory, genetic, biopsy, imaging and endoscopy testing).
    6. Historical, current and forecasted market size data for segmentation based on application type (lung, breast, melanoma, kidney and colorectal cancer).
    7. Analysis of the competitive landscape and profiles of the major companies operating in the market.

    Click on the link to Buy Now@ https://www.qurateresearch.com/report/buy/HnM/QBI-NTS-HnM-60956

    Why buy?

    o Understand the demand of Cancer screening market in the U.S.A. to determine the viability of the market.
    o Identify the developed and emerging markets where cancer screening market in the U.S.A. are sold.
    o Identify the challenge areas and address them.
    o Develop strategies based on the drivers, trends and highlights for each of the segments.
    o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
    o Recognize the key competitors of this market and respond accordingly.
    o Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.
    o Define the competitive positioning by comparing the products and services with the key players in the market.


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) Europe after North America is the second largest market leading the cancer screening market. The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023). Increase in the aging population along with the rise in the number of cancer incidences is a key driving factor for the market. Western Europe is moving fast towards the adoption of performance-based remuneration systems.

    Request for Free Sample@ https://www.qurateresearch.com/report/sample/HnM/QBI-NTS-HnM-60957

    By end users, the market is segmented into hospitals, laboratories and independent physicians and clinics. The Laboratory segment will witness a progressive growth during the forecast period 2018-2023 while the hospital segment will account for the maximum revenue of USD 11.18 billion during the forecast period.
    By screening type, the market is segmented into laboratory, genetic, imaging, biopsy and endoscopy tests. Genetic, biopsy and endoscopy will be the leading segments during the forecast period 2018-2023.
    By application type, the market can be segmented into lung, breast, melanoma, kidney and colorectal cancer types. Colorectal, kidney, melanoma and breast cancer will occupy a larger share of the market during the forecast period 2018-2023.
    By countries, the market is divided into the United Kingdom (U.K.), France and Germany.

    Key growth factors

    Rise in the aging population, changing environmental conditions along with the adoption of a sedentary lifestyle is contributing to more cancer-related cases.

    Threats and key players

    Stringent regulations along with regulatory inter and intra state barriers pose many challenges for the region. Lack of associated funding and transparency in medical procedures turn out to be as threats to the market.
    Key players in the European cancer screening market are F. Hoffman-La- Roche Ltd, Bayer AG, and Johnson & Johnson, Pfizer, Merck & co.

    Enquiry About Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-NTS-HnM-60957

    What is covered in the report?

    1. Overview of the European cancer screening market.
    2. Market drivers and challenges in the European cancer screening market.
    3. Market trends in the European cancer screening market.
    4. Historical, current and forecasted market size data for Europe market segmentation based on type of end users (hospitals, laboratories, independent physicians and clinics) – by type of screening (laboratory, genetic, imaging, biopsy and endoscopy) –by application (lung, breast, melanoma, kidney and colorectal).
    5. Historical, current and forecasted market size data for Europe market segmentation based on end-users (hospitals, laboratories, independent physicians and clinics) – by type of screening type(laboratory, genetic, imaging, biopsy and endoscopy) –by application (lung, breast, melanoma, kidney and colorectal).
    6. Historical, current and forecasted market size data of the cancer screening market by countries UK, Germany and Others (Other parts of Europe) – by revenue .
    7. Historical, current and forecasted market size data for country-wise segments – by revenue.
    8. Analysis of the competitive landscape and profiles of major competitors operating in the European market.

    Click on the link to Buy Now@ https://www.qurateresearch.com/report/buy/HnM/QBI-NTS-HnM-60957

    Why buy?

    o Understand the demand for the cancer screening market to determine the viability of the market.
    o Understand the country-specific market size and observations for each segment.
    o Develop strategies based on the drivers, trends and highlights for each of the segments.
    o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
    o Recognize the key competitors of this market and respond accordingly.
    o Identify the initiatives and growth strategies taken by the major companies and decide the direction of further growth.
    o Define the competitive positioning by comparing the products and services compared with the key players in the market.


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) Companion Animal Healthcare Market Value was worth USD $14.36 Billion in 2018 and estimated to reach USD $19.4 Billion by the end of 2023 with a growing potential at a CAGR of 6.20 %.

    Companion animals are the domesticated animals who are domesticated and whose emotional, physical, behavioural and social needs can be fulfilled by treating them as companions, or having a close regular relationship with humans in their homes. The companies are paying more significance on research and development of new drugs and vaccines for the prevention of newly diagnosed diseases. Companion Animal healthcare market has witnessed a lot of mergers and acquisitions to gain expertise in the development of new pharmaceutical ingredients.

    Get a comprehensive overview of the Europe Companion Animal Health Care Market: http://www.marketdataforecast.com/market-reports/europe-companion-animal-health-care-market-1251/

    Europe Companion Animal Health Care Market: Drivers & Restraints

    Europe Companion Animal health care market is majorly fuelled by factors like increased instances of zoonotic and food borne illnesses, the increasing concern for the health of pet animals, growing pet ownership and increasing demand for nutritious animal food. The major constraints that have the potential to hamper the growth of the market are regulations imposed by different agencies which negatively impact the sales of antibiotics, high costs and increasing restrictions on animal testing. These factors have hampered a number of healthcare companies from preparing newly advanced drugs.

    Get accurate market forecast and analysis on the Europe companion animal healthcare Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/europe-companion-animal-health-care-market-1251/request-sample

    Europe Companion Animal Health Care Market: Segmentation

    By Animals

    Cats
    Dogs
    By Product

    Feed Additives
    Medicine Feed Additives
    Nutritional Feed Additives
    Vaccines
    Pharmaceuticals

    From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/europe-companion-animal-health-care-market-1251/customize-report

    Europe Companion Animal Health Care Market: Overview

    The Europe Companion Animal Health Care Market was valued at USD 3.31 billion as of 2018. As already stated, majority of the market’s growth is likely to come from the increasing awareness about animal healthcare. This market shows evident growth potential during the forecast period. The Nutrition feed additives include vitamins, amino acids and minerals while medical feed additives include probiotics, hormones, immune-modulators, prebiotics and enzymes. The scope of Veterinary medicine is wide, covering many animal species.

    Europe Companion Animal Health Care Market: Region-wise Outlook

    Geographically, the Europe Companion Animal Health care market is analysed under various regions namely U.K, Germany, France, Italy and Spain. The increasing love for pets has been a major reason for the growth of this market in the European countries.

    Key Questions Answered

    What is the current and future Europe Companion Animal Health Care Market outlook? What trends are affecting the market?
    What is the competitive landscape and market share of major players in the Europe Companion Animal Health Care Market?
    What are the key market segments that currently occupy the highest market share in Europe Companion Animal Healthcare Market? Which market segments are growing the fastest?
    What challenges are restraining the growth of the Europe Companion Animal Health Care Market? How will emerging technologies answer these challenges?
    What is physician perception and market outlook of Europe Companion Animal Health Care Market? 

    Europe Companion Animal Health Care Market: Key Players

    Major players in the market include Pfizer Animal health Ltd, Merck & Co Inc., Sanofi Aventis Animal Health, Zoetis Inc., Boehringer Ingelheim GmbH, Elanco Products Company, Bayer AG, Novartis animal Health Inc., Virbac SA, Ceva Sante Animale, Vetoquinol SA.

    Reasons to buy Europe Companion Animal Health Care Market Report:

    Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
    Segment-level analysis on basis of animals and product along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
    Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
    Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
    A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
    Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
    Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market 

    Checkout other related studies in the Animal Healthcare Segment:

    Companion Animal Healthcare Market: http://www.marketdataforecast.com/market-reports/global-companion-animal-health-care-market-1249/

    Europe Veterinary Vaccines Market: http://www.marketdataforecast.com/market-reports/europe-veterinary-vaccines-market-81/

    Europe Veterinary Diagnostics Market: http://www.marketdataforecast.com/market-reports/europe-veterinary-diagnostics-market-87/ 

    About Market Data Forecast:

    Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.

     

    Contact:

    Abhishek Shukla

    Sales Manager (International Business Development)

    Market Data Forecast

    Direct Line: +1-888-702-9626

    Mobile: +91 998 555 0206

    Mail: abhishek@marketdataforecast.com

    Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/

    View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) Overview

    Companion animals are the animals which serve man by giving companionship and guarding their homes or offices. Various varieties of sicknesses in animals and their switch to humans through their product intake and companionship are escalating the market globally.

    Companion animals are domesticated animals which are saved usually for person’s companionship and amusement instead of as a livestock, working animal or laboratory animal. A companion animal consists of a dog, cat, fish, hen, horse, rabbit, hamster, guinea pig, and ferret. in step with the countrywide pet proprietors Survey in 2017, performed by means of American doggy merchandise association (APPA), round 68% of the household owns a companion animal drug includes veterinary and over the counter drugs, supplements, nutraceuticals, vaccines, antibiotics, and Parasiticides, that are used in the treatment of ailment associated with digestive system, immunological device, reproductive system, respiration, and urinary device.

    View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-companion-animal-health-care-market-1252/request-sample

    Asia Pacific companion Animal Healthcare market changed into well worth USD 2.3 Billion in 2018 and estimated to attain USD 3.12 Billion by 2023 with a CAGR of 6.30 %.

    Drivers and Restraints:

    Conventionally, the distinction among animal manufacturing and animal health has been changing within the modern-day times because of the developing occurrence of animal illnesses. Developing occurrence of infectious and parasitic illnesses has led to a subsequent wave of innovation in coping with animal health. Modern-day medication in association with era is focused on enhancing animal health and cattle production.

    The restraints for you to avoiding the increase of the market are regulations by regulatory our bodies have an awful impact on the earnings of antibiotics, soaring fees and developing policies on animal sorting out have hindered a number of healthcare companies from production newly advanced capsules.

    To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-companion-animal-health-care-market-1252/

    Geographic Segmentation

    Primarily based on Geography, the Asia-Pacific companion Animal Healthcare market is analyzed under various regions particularly China, Japan, India, and Australia. Asia pacific holds the most essential proportion of the market due to developing expenditure on domestic dog vitamins and Healthcare.

    Get your customized report: https://www.marketdataforecast.com/market-reports/asia-pacific-companion-animal-health-care-market-1252/customize-report

    The dominating companies dominating the market include Pfizer Animal health Ltd, Merck & Co Inc., Sanofi Aventis Animal Health, Zoetis Inc., Boehringer Ingelheim GmbH, Elanco Products Company, Bayer AG, Novartis Animal Health Inc., Virbac SA, Ceva Sante Animale, Vetoquinol SA. 

    Scope of the report

    The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

    The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

    What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

    Contact Info:
    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Above ICICI Bank, B-44, Rd Number 3, Journalist Colony,

    Film Nagar, Hyderabad, Telangana 500033, India.

    Phone: +1-888-702-9626


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 07, 2018 ) The Global Curcumin Industry research 2023 exploring the current market revenue, demand, size, trend, overview, shares, and growth with the help of tables and figures , complete report with 135 pages, figures, graphs and table of contents to analyze the situations of global Curcumin market and assessment to 2023.

    Request for Sample Copy at https://www.researchreportsinc.com/sample-request?id=30506

    For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023.
    This report covers following regions:
    • North America
    • South America
    • Asia & Pacific
    • Europe
    • MEA (Middle East and Africa)
    The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
    Furthermore, years considered for the study are as follows:
    • Historical year – 2013
    • Base year – 2018
    • Forecast period – 2018 to 2023

    Enquiry more at https://researchreportsinc.com/enquiry?id=30506

    For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.
    For competitor segment, the report includes global key players of Curcumin as well as some small players.
    The information for each competitor includes:
    • Company Profile
    • Main Business Information
    • SWOT Analysis
    • Sales, Revenue, Price and Gross Margin
    • Market Share
    We also can offer customized report to fulfill special requirements of our clients.

    Buy Now at https://researchreportsinc.com/checkout/?add-to-cart=30506&&attribute_pa_choose-license=single-user&&quantity=1

    Major points from table of contents for global Curcumin industry 2023 market research report include:
    Chapter 1 Executive Summary
    Chapter 2 Abbreviation and Acronyms
    Chapter 3 Preface
    Chapter 4 Market Landscape
    Chapter 5 Market Trend Analysis
    Chapter 6 Industry Chain Analysis
    Chapter 7 Latest Market Dynamics
    Chapter 8 Trading Analysis
    Chapter 9 Historical and Current Curcumin Market in North America (2013-2018)
    Chapter 10 Historical and Current Curcumin Market in South America (2013-2018)
    Chapter 11 Historical and Current Curcumin Market in Asia & Pacific (2013-2018)
    Chapter 12 Historical and Current Curcumin Market in Europe (2013-2018)
    Chapter 13 Historical and Current Curcumin Market in MEA (2013-2018)
    Chapter 14 Summary for Global Curcumin Market (2013-2018)
    Chapter 15 Global Curcumin Market Forecast (2019-2023)

    About us:
    Research reports Inc. is one of the leading destinations for market research reports across all industries, companies, and technologies. Our repository features an exhaustive list of market research reports from thousands of publishers worldwide
    contact us for your special interest needs and we will get in touch within 24hrs to help you find the market research report you need.
    With our expertise and research offerings, we ensure we deliver on all your requirements, whether you’re looking for industry analysis or market trends or anything else, first time and every time!
    Email us sales@researchreportsinc.com
    Call us +18554192424 +4403308087757




    Shubham Goel
    8554192424
    pressrelease@researchreportsinc.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 07, 2018 ) The Global HPV Vaccine Industry research 2023 exploring the current market revenue, demand, size, trend, overview, shares, and growth with the help of tables and figures , complete report with 135 pages, figures, graphs and table of contents to analyze the situations of global HPV Vaccine market and assessment to 2023.

    Request for Sample Copy at https://www.researchreportsinc.com/sample-request?id=30706

    For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023.
    This report covers following regions:
    • North America
    • South America
    • Asia & Pacific
    • Europe
    • MEA (Middle East and Africa)
    The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
    Furthermore, years considered for the study are as follows:
    • Historical year – 2013
    • Base year – 2018
    • Forecast period – 2018 to 2023

    Enquiry more at https://researchreportsinc.com/enquiry?id=30706

    For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.
    For competitor segment, the report includes global key players of HPV Vaccine as well as some small players.
    The information for each competitor includes:
    • Company Profile
    • Main Business Information
    • SWOT Analysis
    • Sales, Revenue, Price and Gross Margin
    • Market Share
    We also can offer customized report to fulfill special requirements of our clients.

    Buy Now at https://researchreportsinc.com/checkout/?add-to-cart=30706&&attribute_pa_choose-license=single-user&&quantity=1

    Major points from table of contents for global HPV Vaccine industry 2023 market research report include:
    Chapter 1 Executive Summary
    Chapter 2 Abbreviation and Acronyms
    Chapter 3 Preface
    Chapter 4 Market Landscape
    Chapter 5 Market Trend Analysis
    Chapter 6 Industry Chain Analysis
    Chapter 7 Latest Market Dynamics
    Chapter 8 Trading Analysis
    Chapter 9 Historical and Current HPV Vaccine Market in North America (2013-2018)
    Chapter 10 Historical and Current HPV Vaccine Market in South America (2013-2018)
    Chapter 11 Historical and Current HPV Vaccine Market in Asia & Pacific (2013-2018)
    Chapter 12 Historical and Current HPV Vaccine Market in Europe (2013-2018)
    Chapter 13 Historical and Current HPV Vaccine Market in MEA (2013-2018)
    Chapter 14 Summary for Global HPV Vaccine Market (2013-2018)
    Chapter 15 Global HPV Vaccine Market Forecast (2019-2023)

    About us:
    Research reports Inc. is one of the leading destinations for market research reports across all industries, companies, and technologies. Our repository features an exhaustive list of market research reports from thousands of publishers worldwide
    contact us for your special interest needs and we will get in touch within 24hrs to help you find the market research report you need.
    With our expertise and research offerings, we ensure we deliver on all your requirements, whether you’re looking for industry analysis or market trends or anything else, first time and every time!
    Email us sales@researchreportsinc.com
    Call us +18554192424 +4403308087757




    Shubham Goel
    8554192424
    pressrelease@researchreportsinc.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 07, 2018 ) The Global Artificial Insemination Industry research 2023 exploring the current market revenue, demand, size, trend, overview, shares, and growth with the help of tables and figures , complete report with 135 pages, figures, graphs and table of contents to analyze the situations of global Artificial Insemination market and assessment to 2023.

    Request for Sample Copy at https://www.researchreportsinc.com/sample-request?id=31230

    For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023.
    This report covers following regions:
    • North America
    • South America
    • Asia & Pacific
    • Europe
    • MEA (Middle East and Africa)
    The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
    Furthermore, years considered for the study are as follows:
    • Historical year – 2013
    • Base year – 2018
    • Forecast period – 2018 to 2023

    Enquiry more at https://researchreportsinc.com/enquiry?id=31230

    For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.
    For competitor segment, the report includes global key players of Artificial Insemination as well as some small players.
    The information for each competitor includes:
    • Company Profile
    • Main Business Information
    • SWOT Analysis
    • Sales, Revenue, Price and Gross Margin
    • Market Share
    We also can offer customized report to fulfill special requirements of our clients.

    Buy Now at https://researchreportsinc.com/checkout/?add-to-cart=31230&&attribute_pa_choose-license=single-user&&quantity=1

    Major points from table of contents for global Artificial Insemination
    industry 2023 market research report include:
    Chapter 1 Executive Summary
    Chapter 2 Abbreviation and Acronyms
    Chapter 3 Preface
    Chapter 4 Market Landscape
    Chapter 5 Market Trend Analysis
    Chapter 6 Industry Chain Analysis
    Chapter 7 Latest Market Dynamics
    Chapter 8 Trading Analysis
    Chapter 9 Historical and Current Artificial Insemination Market in North America (2013-2018)
    Chapter 10 Historical and Current Artificial Insemination Market in South America (2013-2018)
    Chapter 11 Historical and Current Artificial Insemination Market in Asia & Pacific (2013-2018)
    Chapter 12 Historical and Current Artificial Insemination Market in Europe (2013-2018)
    Chapter 13 Historical and Current Artificial Insemination Market in MEA (2013-2018)
    Chapter 14 Summary for Global Artificial Insemination Market (2013-2018)
    Chapter 15 Global Artificial Insemination Market Forecast (2019-2023)

    About us:
    Research reports Inc. is one of the leading destinations for market research reports across all industries, companies, and technologies. Our repository features an exhaustive list of market research reports from thousands of publishers worldwide
    contact us for your special interest needs and we will get in touch within 24hrs to help you find the market research report you need.
    With our expertise and research offerings, we ensure we deliver on all your requirements, whether you’re looking for industry analysis or market trends or anything else, first time and every time!
    Email us sales@researchreportsinc.com
    Call us +18554192424 +4403308087757




    Shubham Goel
    8554192424
    pressrelease@researchreportsinc.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) Overview:

    In the year 2018, Europe HIV Diagnostics Market was valued at USD 500 Million. By the year 2023, it is expected to reach USD 770 Million at pace of 9.20% CAGR.

    Acquired Immuno deficiency Syndrome (AIDS) is caused by Human Immuno deficiency Virus (HIV). These HIV diagnostic tests are performed to detect the presence of the virus. The diagnosis of HIV is based on several methods, such as salivary test, blood test, viral load test, Western Bloat method and Enzyme Linked Immunosorbent Assay (ELISA) test. The Western blot technique is used to detect anti-HIV antibodies in the human serum sample and the ELISA assay uses the antibodies to identify the substance.

    View sample and decide: https://www.marketdataforecast.com/market-reports/europe-hiv-diagnostics-market-2147/request-sample

    Underlying Causes

    The growth for HIV Diagnostics Market is driven due to factors like increasing prevalence of prevalence infections, rising governmental initiatives to promote awareness about HIV among people, growing demand for HIV/AIDS diagnostics, and rising healthcare expenditure. In addition, increasing investments for R&D activities, advancement of technologies, and introduction of novel techniques for diagnosis and eradication of HIV infection is expected to drive the market growth. However, lack of skilled professionals, and failure of treatment in some cases is expected to hinder the growth rate for Europe HIV Diagnostics Market during the forecast period.

    To know more read: https://www.marketdataforecast.com/market-reports/europe-hiv-diagnostics-market-2147/

    Geographic Segmentation:

    Based on geography the Europe HIV Diagnostics Market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. Europe holds the third position in HIV Diagnostics Market, which is expected to have a steady growth rate during the forecast period.

    Get your customized report: https://www.marketdataforecast.com/market-reports/europe-hiv-diagnostics-market-2147/customize-report

    Key Players:

    Leading companies for Europe HIV Diagnostics Market are Abbott Healthcare, Brsitol-Myers Squibb, Alere Inc., Abbvie Inc., Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, BD Biosciences, Beckman Coulter, Partec, Sysmex, VIIV Healthcare, Apogee Flow Systems, Mylan inc., PointCare Technologies Inc., Zyomyx Inc., Roche Diagnostics, Qiagen, Siemens Healthcare, and bioMerieux.

    About MarketDataForecast™

    Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.

    Contact Information:

    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Above ICICI Bank Filmnagar Branch, B 44, Rd Number 3, Journalist Colony, Hyderabad, Telangana 500033.

    Phone: +1-888-702-9626


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 06, 2018 ) Overview

    Acquired Immunodeficiency Syndrome (AIDS) is as a result of human immunodeficiency virus (HIV). Due to the fact the demand for proposes, HIV diagnosis checks are achieved to come across the presence of the virus. The HIV diagnosis may be performed by blood take a look at, saliva takes a study, viral load test, even though the greenest test consequences are received by Enzyme connected Immunosorbent Assay (ELISA) check initially and later by Western Blot method.

    The Human Immunodeficiency Virus (HIV) is a retrovirus that attacks the immune device of human beings and weakens the individual’s protection tool against infections. It assaults and destroys the T-helper cells, a form of white blood cells, and replicates and produces more than one copies of itself in the one's white blood cells. T-helper cells are also called CD4 cells. Frequently the immune system becomes susceptible and susceptible to any kind of infections.

    View sample and decide: https://www.marketdataforecast.com/market-reports/asia-pacific-hiv-diagnostics-market-2148/request-sample

    Asia Pacific HIV Diagnostics market becomes well worth USD 680 million in 2018 and is predicted to be developing at a CAGR of 10.40%, to attain 1,110 million by 2023.

    Drivers and Restraints:

    Increasing occurrence of HIV has precipitated developing issue for few of the government using them to often spend money on sports geared towards curbing illness burden expenses of HIV/AIDS. Multinational healthcare institutions inclusive of UNITAID promote attention and resource in locating novel techniques for analysis and eradication of HIV contamination. Federal initiative through the authorities of Canada for treatment of HIV/AIDS at extraordinary levels of development of this sickness is anticipated to power utilization of HIV diagnostic tests.

    Even though HIV prognosis is the basic requirement for prevention and remedy of AIDS, in a few underdeveloped nations, scarcity of price range and the need for a technological device to run general assessments, in conjunction with skilled experts, and inaccuracy of the test, restraints the extensive attractiveness of HIV diagnosis market.

    To know more read: https://www.marketdataforecast.com/market-reports/asia-pacific-hiv-diagnostics-market-2148/

    Geographic Segmentation

    On the basis of geography, the Asia Pacific marketplace is analyzed beneath various regions namely India, China, South Korea, Japan, and Australia. North America was observed by the Asia Pacific in terms of sales. The Asia Pacific is expected to grow at a fast pace in the coming few years, due to its high unmet demand for India and China.

    Get your customized report: https://www.marketdataforecast.com/market-reports/asia-pacific-hiv-diagnostics-market-2148/customize-report

    The prominent players of the market include Abbott Healthcare, Brsitol-Myers Squibb, Alere Inc., Abbvie Inc., Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Zyomyx Inc., Apogee Flow Systems, Mylan inc., PointCare Roche Diagnostics, Technologies Inc., Qiagen, Siemens Healthcare, and bioMerieux. 

     

    Scope of the report

    The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

    The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

    What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

    Contact Info:
    Name: Mr. Abhishek Shukla
    Email: abhishek@marketdataforecast.com
    Organization: MarketDataForecast™
    Address: 2nd Floor, Above ICICI Bank, B-44, Rd Number 3, Journalist Colony,

    Film Nagar, Hyderabad, Telangana 500033, India.

    Phone: +1-888-702-9626


    Abhishek Shukla
    +1-888-702-9626
    abhishek@marketdataforecast.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 07, 2018 ) Goodpasture Syndrome Treatment Market: Introduction

    The Goodpasture syndrome is a rare autoimmune and life-threatening disease. It affects both kidneys and lungs. The Goodpasture syndrome was first identified by Dr. Ernest Goodpasture in 1919. It is also known as anti-GBM disease. In goodpasture syndrome, antibodies are produced against a specific region of collagen in kidneys and lungs. The initial symptoms of goodpasture syndrome are fatigue, loss of appetite, vomiting, and pale appearance. Sometimes, the symptoms of goodpasture syndrome become life-threatening and cause respiratory failure, especially if there is a lot of bleeding. The Goodpasture syndrome majorly affects the kidney and causes a burning sensation during urination, swelling of hands and feet, back pain, elevated blood pressure readings and others. Goodpasture syndrome treatment involves medications which slow down the immune system. The treatment depends on the age, overall health of an individual and severity of the disease. The diagnosis of goodpasture syndrome can be done through urinalysis, blood test, chest X-ray and biopsy. Presently, the exact cause of goodpasture syndrome is still not known. Goodpasture syndrome develops due to unknown causes. Cigarette smoke, hydrocarbon chemical exposure and infections, such as influenza, may be some of the causing factors. The goodpasture syndrome can become fatal if not diagnosed and treated on time. In severe cases, goodpasture syndrome treatment includes procedures where waste products are removed from the blood. In most severe cases, goodpasture syndrome treatment requires kidney transplantation. Goodpasture syndrome treatment reduces the severity of the symptoms. In addition, the treatment also prevents the destruction of lung tissues and kidney. 

    Get Experts' Insights For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1503

    Goodpasture Syndrome Treatment Market: Drivers and Restraints

    The growing prevalence of unhealthy lifestyle and increasing geriatric population are the major factors driving the growth of the global goodpasture syndrome treatment market. In addition, other factors, such as utilization of hair dyes, usage of tobacco and exposure to hydrocarbons, etc. are also driving the growth of the global goodpasture syndrome treatment market. Moreover, increasing number of clinical trials, robust R&D and increasing awareness in developed countries are major factors anticipated to drive the growth of the goodpasture syndrome treatment market. According to the National Organization for Rare Disorders, the goodpasture syndrome affects males more frequently than females. Presently, around 600 cases of goodpasture syndrome have been observed in medical literature. According to the Clinical Kidney Journal, it is estimated that goodpasture syndrome affects one of one million people per year. However, stringent regulations and difficulties in diagnosis are some of the factors which are expected to hamper the growth of the global goodpasture syndrome treatment market during the forecast period.

    Goodpasture Syndrome Treatment Market: Segmentation

    The global goodpasture syndrome treatment market can be segmented on the basis of treatment type, end user and geography.

    Based on treatment type, the global goodpasture syndrome treatment market is segmented into:

    Immunosuppressive Drugs
    Methylprednisolone
    Cyclophosphamide
    Corticosteroids
    Others
    Based on End User, the global goodpasture syndrome treatment market is segmented into:

    Hospitals
    Clinic
    Ambulatory Surgical Centers
    Others
    Goodpasture Syndrome Treatment Market: Overview

    The global market for goodpasture syndrome treatment is expected to witness moderate growth rate over the forecast period.  Immunosuppressive drugs are expected to contribute the major revenue share to the goodpasture syndrome treatment market. The hospital end-user segment is expected to contribute maximum market share to the global goodpasture syndrome treatment market. Medications for a mild form of goodpasture syndrome treatment include immunosuppressive drugs (like cyclophosphamide), corticosteroids (like prednisone) plasmapheresis and others. Goodpasture syndrome treatment controls the antibodies in the blood and also reduces the risk of infections. Plasmapheresis is a procedure used to remove unwanted substances, such as damaging antibodies, toxins and metabolic substances from the blood. Plasmapheresis is often administered in combination with corticosteroid treatment. Plasmapheresis is under investigation for goodpasture syndrome treatment and other autoimmune disorders.

    Request Customized Report As Per Your Requirements: 
    rnhttps://www.factmr.com/connectus/sample?flag=RC&rep_id=1503

    Goodpasture Syndrome Treatment Market: Regional Outlook

    Geographically, the global goodpasture syndrome treatment market is segmented into North America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is anticipated to be the dominant market in the global goodpasture syndrome treatment market owing to the growing unhealthy lifestyle and drug abuse. Europe is expected to hold second-largest share in the global goodpasture syndrome treatment market throughout the forecast period owing to high awareness regarding health-related problems. The goodpasture syndrome treatment market in the Asia Pacific excluding Japan is expected to grow at a rapid pace at a significant CAGR, primarily due to the growing geriatric population and increasing healthcare facilities.  

    Goodpasture Syndrome Treatment Market: Key Players

    Examples of some of the key players operating in the global goodpasture syndrome treatment market are Amneal Pharmaceuticals, Inc., Bristol-Myers Squibb, Sandoz Inc. and others.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

    The report covers exhaustive analysis on:

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies Involved
    Technology
    Value Chain
    Regional analysis includes:

    North America (U.S., Canada)
    Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
    Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
    CIS & Russia
    Japan
    Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
    Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint
    For more information about this report visit https://www.factmr.com/report/1503/goodpasture-syndrome-treatment-market


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 07, 2018 ) Leprosy is chronic infectious disease caused by Mycobacterium leprae. Leprosy is also referred to as Hansen’s disease. Leprosy affects the skin, mucosal surfaces of the upper respiratory tract, the peripheral nerves and the eyes. Leprosy can occur to the people of all ages from infant to geriatric. The exact reason for transmission of leprosy is not known but it is strongly believed that leprosy is transferred from a leprosy patient to a healthy person. The delay diagnosis of leprosy may cause some serious complication such as muscle weakness, erectile dysfunction, kidney failure, blindness, among others. The best way to prevent leprosy is to avoid contact with infected and untreated people and do vaccination with leprosy vaccines. Leprosy is a curable disease but it takes too much time to recover, hence doctors are prescribing the leprosy vaccines to infants. Leprosy vaccine was first introduced in 1921 by Dr. Albert Calmette and Dr. Cammille Guerin. BCG vaccine is the most commonly prescribed leprosy vaccines for the prevention of leprosy among the infants.

    Leprosy Vaccines Market: Drivers and Restraints

    Increasing prevalence of skin diseases is the primary factor driving the growth of Leprosy Vaccines Market over the forecast period. Skin diseases such as leprosy and psoriasis are becoming common disease conditions in some of the countries in Asia-Pacific which is responsible for the robust growth of Leprosy Vaccines market. Rising government initiative and favorable reimbursement scenario for the Leprosy Vaccines will also propel the growth of Leprosy Vaccines market. On other hand, lack of awareness among people about leprosy vaccines will deter the growth of leprosy vaccines market to some extent. Additionally, the stringent regulatory scenario by FDA for the approval of vaccine will also be responsible for sluggish growth of the leprosy vaccines market during the forecast period.

    Get Experts' Insights For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1502

    Leprosy Vaccines Market: Segmentation

    Tentatively, the global leprosy vaccines market can be segmented on the basis of vaccine type, route of administration, distribution channel, and geography.

    Based on vaccine type, the global Leprosy Vaccines market is segmented as:

    BCG
    BCG + killed M. leprae
    ICRC
    Mw
    Habana
    Vaccae
    Based on route of administration, the global Leprosy Vaccines market is segmented as:

    Oral
    Injectable
    Based on end user, the global Leprosy Vaccines market is segmented as:

    Hospitals
    Ambulatory Care Centers
    Leprosy Vaccines Market: Overview

    The leprosy vaccines market is expected to show exponential growth over the forecast period owing to rising patient pool of leprosy in Asia-Pacific. According to WHO, the prevalence of leprosy in 2015 was 176 cases per 10000 people. About 60% of world leprosy patients live in India. Therefore, India is the major market throughout the globe for leprosy vaccines. BCG vaccine is commonly prescribed by the physicians for Leprosy prevention, therefore by vaccine type BCG vaccine segment is expected to gain maximum market share over the forecast period for global leprosy vaccines market. But, BGC vaccine is not prescribed by the physicians in the U.S. because of the unproven effectiveness of the BCG vaccine as well as the low incidence of leprosy patients in America which is responsible for sluggish growth of leprosy vaccines market. Among all end users, ambulatory care center is the fastest growing segment in the global leprosy vaccines market due increasing number of vaccination in this end user facility.

    Leprosy Vaccines Market: Regional Outlook

    Geographically, the global Leprosy Vaccines market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). Asia-Pacific is expected to gain maximum market share for global leprosy vaccines in term of revenue owing to high patient pool of leprosy in India and China.  After APEJ Leprosy Vaccines market is followed by Japan and Latin America owing to increasing awareness among the patient about Leprosy Vaccines in this regions. MEA is expected to grow at faster rate than other region for leprosy vaccines due to rising government initiative to for the awareness of Leprosy Vaccines. North America, Western Europe and Eastern Europe is the least lucrative market for Leprosy Vaccines due to lack of patient pool in these regions.

    Request Customized Report As Per Your Requirements: 
    rnhttps://www.factmr.com/connectus/sample?flag=RC&rep_id=1502

    Leprosy Vaccines Market: Key Players

    Some of the key players operating in the global Leprosy Vaccines Market are Pfizer Inc., GlaxoSmithKline PLC, Cadila Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Organon Laboratories Lmt., Sanofi AG, GreenSignal Bio Pharma Private Limited, Merck & Co., Inc, and others.

    The leprosy vaccine market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The leprosy vaccine market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    The report covers exhaustive analysis on:

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies involved
    Technology
    Value Chain
    Regional analysis includes

    North America (U.S., Canada)
    Latin America (Mexico, Brazil)
    Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
    Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
    Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
    Japan
    Middle East and Africa (GCC, S. Africa, Rest Of MEA)
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint
    For more information about this report visit https://www.factmr.com/report/1502/leprosy-vaccines-market


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 07, 2018 ) Orthopedic repair is also called orthopedic surgery or orthopedics, which is a branch of medicine that deals with the conditions involving the musculoskeletal system. Orthopedic doctors use both, surgical and non-surgical means to treat musculoskeletal anomalies, spinal anomalies, and sports and trauma injuries. Orthopedic repair is basically performed on the musculoskeletal system. This includes the bones, joints, muscles, ligaments, cartilages, nerves, and connective tissues which bind various parts of the body together. A musculoskeletal anomaly in any part of the body can have an enormous impact on an individual’s day-to-day activities. There are a range of treatments in order to correct such problems. The most common treatment method for various orthopedic injuries and conditions is the construction and repair of the injured body part with a surgery. Surgical construction and repair of a joint, bone, muscle, cartilage or nerve can be completed with various procedures like fusion, internal fixation, osteotomy, soft tissue repair, and arthroscopy.

    Orthopedic Repair Market: Drivers and Restraints

    The growing prevalence and recurrence of diverticular disease is expected to be the major factor driving the growth of the Orthopedic Repair Market over the forecast period. It is anticipated that several areas will affect the orthopedic repair market. Patient-specific surgeries and implants are expected to drive the orthopedic repair market. Various tools have been developed in the orthopedic repair market in order to improve accuracy, and also by customizing surgical cutting blocks to a patient’s anatomy. In personalized healthcare, various surgeries in the orthopedic repair market, such as spinal, maxillofacial, and prosthetic devices will drive the orthopedic repair market. However, high prices and lack of awareness in developing economies are expected to hinder the growth of the orthopedic repair market.

    Get Experts' Insights For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1501

    Orthopedic Repair Market: Segmentation

    Tentatively, the global orthopedic repair market can be segmented on the basis of surgery type, end user, and geography.

    Based on surgery type, the global orthopedic repair market is segmented as:

    Upper Extremity
    Shoulder Anthroscopy
    Shoulder Surgery
    Maxillofacial Surgery
    Shoulder Replacement
    Orthogonathic Surgery
    Hand Surgery
    Wrist Surgery
    Lower Extremity
    Anterior Crutiate Ligament Reconstruction
    Knee Replacement Surgery
    Tibial Nailing
    Minimally Invasive Forefoot Surgery
    Femoral Fracture Surgery
    Meniscal Transplantation
    Hip Surgery
    Hip Replacement
    Spinal Surgery
    Spinal Surgery
    Spinal Osteosynthesis Surgery
    Percutaneous Kyphoplasty
    Percutaneous Vertebroplasty
    Inter-body Fusion Surgery
    Bones
    Bone Cement Injection
    Bone Grafting
    Traumatology
    Based on end user, the global orthopedic repair market is segmented as:

    Hospitals
    Orthopedic Clinics
    Ambulatory Surgical Centers
    Trauma Centers
    Based on geography, the global orthopedic repair market is segmented as:

    North America
    S.
    Canada
    Latin America
    Brazil
    Mexico
    Argentina
    Chile
    Peru
    Rest of LATAM

    Europe
    EU – 4 (Germany, France, Italy, Spain)
    K.
    BENELUX (Belgium, Netherlands, Luxemburg)
    NORDIC (Norway, Denmark, Iceland, Sweden)
    Eastern Europe (Poland, Ukraine, Czech Rep., etc.)
    Rest of Europe
    CIS & Russia
    Japan
    APEJ
    Greater China
    India
    Korea
    ASEAN Countries
    Rest of APEJ
    Middle East & Africa
    GCC Countries
    Turkey
    Iran
    Israel
    South Africa
    Rest of MEA
    Orthopedic Repair Market: Overview

    The global market for orthopedic repair is expected to witness moderate growth over the forecast period. A majority of the surgeries are readily available in various hospitals, orthopedic clinics, ambulatory surgical centers, and specialty clinics. Amongst the end users in Orthopedic Repair market, the hospitals and ambulatory surgical centers segments are expected to lead in the global orthopedic repair market over the forecast period. Amongst the surgery types, the global orthopedic repair market is expected to be dominated by spinal and lower extremity surgeries, owing to the increasing incidences of spinal and lower extremity anomalies.

    Request Customized Report As Per Your Requirements: 
    rnhttps://www.factmr.com/connectus/sample?flag=RC&rep_id=1501

    Orthopedic Repair Market: Regional Outlook

    Geographically, the global orthopedic repair market is segmented into North America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global orthopedic repair market, owing to the high prevalence of orthopedic anomalies. The orthopedic repair market in Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to the expansion of product offerings by key players. Europe is expected to have the second-largest share in the global orthopedic repair market throughout the forecast period.

    Orthopedic Repair Market: Key Players

    The global market for Orthopedic Repair Market is highly fragmented. Examples of some of the key players operating in the global orthopedic repair market are Zimmer Biomet, Z-Medical GmbH + Co. KG, USTOMED INSTRUMENTE, Synimed Synergie Ingénierie Médicale SARL, Stryker Corporation, Joline GmbH & Co. KG, JEIL MEDICAL CORPORATION, iMEDICOM, EgiFix Medical, and others.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

    The report covers exhaustive analysis on:

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies Involved
    Technology
    Value Chain
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint
    For more information about this report visit https://www.factmr.com/report/1501/orthopedic-repair-market


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 07, 2018 ) Diuretic Drugs are also known as 'water pills'. Diuretic drugs get rid of extra water in the body and lower blood pressure. Diuretic drugs are a class of drugs that increase the flow of urine in the body. They do so by reducing the sodium and chloride concentration in the body by removing it through the urine. This leads the body to draw excess water from the body. The sodium and chloride concentration in the body has a marked effect on the amount of water retained within the body. Hence, most of the diuretic drugs have their effects by reducing the body’s sodium and chloride content. Diuretic drugs are also used in combination along with various types of medications. They are useful in edema caused by renal dysfunction, and solely used as therapeutic agents to treat hypertension. As per the World Health Organization (WHO), increasing blood pressure accounts for an estimated 7.5 million deaths worldwide, and around 12.8% of the total deaths annually. Globally, the overall prevalence of blood pressure in adults aged over 25 was around 40% in 2008.

    Diuretic Drugs Market: Drivers and Restraints

    The growing prevalence and recurrence of kidney stones, heart failure, and high blood pressure is expected to be the major factor driving the growth of the Diuretic Drugs Market over the forecast period. According to the World Health Organization, cardiac disease is the number one cause of death, globally. An estimated 17.2 million people die from cardiac diseases, representing a total of 31% of global deaths annually. Approximately 7.4 million deaths were due to coronary heart disease, and approximately 6.7 million were due to stokes, which is expected to further drive the diuretic drugs market. Changes is lifestyle and eating habits are attributed to the growing prevalence of diuretic drugs. The launch and addition of new therapies is another factor contributing to the growth of the global diuretic drugs market.

    Get Experts' Insights For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1500

    Diuretic Drugs Market: Segmentation

    Tentatively, the global diuretic drugs market can be segmented on the basis of product type, indication, distribution channel, and geography.

    Based on product type, the global diuretic drugs market is segmented as:

    Loop Diuretics
    Thiazide Diuretics
    Potassium-sparing Diuretics
    Carbonic anhydrase Inhibitors
    Based on indication, the global diuretic drugs market is segmented as:

    Hypertension
    Glaucoma
    Heart Failure
    Kidney Stones
    Based on distribution channel, the global diuretic drugs market is segmented as:

    Hospital Pharmacies
    Independent Pharmacies
    Retail Pharmacies
    Drug Stores
    Online Pharmacies
    Based on geography, the global diuretic drugs market is segment as:

    North America
    Latin America
    Western Europe
    Eastern Europe
    Asia Pacific excluding Japan
    Japan
    Middle-East & Africa
    Diuretic Drugs Market: Overview

    The global market for diuretic drugs is expected to witness moderate growth over the forecast period. A majority of the drugs are introduced in the generic market, and thus, there exists high competition among local and regional players. Amongst the four Diuretic drugs product types, the loop diuretic drugs segment is expected to lead the global diuretic drugs market over the forecast period. The pharmacies sub-segment under the distribution channel segment is expected to contribute a high share in the global diuretic drugs market, as it is the most accessible channel and a majority of patients are recommended Diuretic drugs.

    Diuretic Drugs Market: Regional Outlook

    Geographically, the global diuretic drugs market is segmented into North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global diuretic drugs market, owing to the high prevalence of the diuresis, edema and other diuretic anomalies. The diuretic drugs market in Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to the expansion of product offerings by key players. Europe is expected to have the second-largest share in the global diuretic drugs market throughout the forecast period.

    Request Customized Report As Per Your Requirements: 
    rnhttps://www.factmr.com/connectus/sample?flag=RC&rep_id=1500

    Diuretic Drugs Market: Key Players

    The global market for diuretic drugs is highly fragmented. Examples of some of the key players operating in the global diuretic drugs market are Sanofi-aventis U.S. LLC, Centaur Pharmaceuticals Pvt Ltd, Validus Pharmaceuticals LLC, Meda Manufacturing GmbH, Valeant Pharmaceuticals International, Inc., Actavis Generics, Pfizer Inc., Merck & Co., Inc., Paddock Laboratories, LLC., and Perrigo Pharmaceuticals Company, among others.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

    The report covers exhaustive analysis on:

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies Involved
    Technology
    Value Chain
    Regional analysis includes:

    North America (U.S., Canada)
    Latin America (Mexico, Brazil)
    Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
    Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
    Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
    Japan
    Middle East and Africa (GCC, S. Africa, Rest Of MEA)
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint
    For more information about this report visit https://www.factmr.com/report/1500/diuretic-drugs-market


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 07, 2018 ) Vertebral compression fracture is one of the most common osteoporotic fractures, which leads to kyphotic deformities, depression, weight loss, reduced quality of life, persistent pain and even death. Osteoporosis is a major cause of vertebral compression fracture in elderly women. Multiple myeloma, metastatic bone disease, traumatic injuries and metastatic spinal tumors can also lead to vertebral compression fractures. According to the International Journal of Surgery-Elsevier, VCF occurs in 16% of women post-menopause and in 20% of people older than 70 years of age. People suffering from vertebral compression fracture can opt for either kyphoplasty or vertebroplasty. Kyphoplasty systems use a minimally-invasive approach and the procedure can be carried out on outpatient as well as inpatient basis. Kyphoplasty systems have proved to be more efficient than non-surgical care for treating acute vertebral compression fractures.

    Kyphoplasty Systems Market: Drivers

    Growing prevalence of osteopenia and osteoporosis due to the increasing elderly population and growing demand for outpatient and minimal invasive procedures are driving the growth of the Kyphoplasty Systems Market. Vertebral compression fractures caused by benign lesions, cancer and osteoporosis are gaining prevalence in the market. The kyphoplasty systems market is also influenced by the advantages of minimally invasive and cost-saving equipment procedures. Good reimbursement policies by local governments are contributing to the growth of kyphoplasty systems as well. However, certain complications such as damage of the surrounding spinal nerves and canal, allergy to the solution placed to view the balloon on and X-ray image, introduction of novel devices such as vertebral augmentation implants and vertebral body stents in the market and the high-cost of surgery might hinder the growth of the kyphoplasty systems market over the forecast period.

    Get Experts' Insights For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1499

    Kyphoplasty Systems Market: Segmentation

    Tentatively, the global kyphoplasty systems market can be segmented on the basis of product type, end user and geography.

    Based on product type, the global kyphoplasty systems market has been segmented as,

    Balloon Kyphoplasty Systems
    Needle Kyphoplasty Systems
    X-Ray Device Kyphoplasty Systems
    Based on application type, the global kyphoplasty systems market has been segmented as,

    Restoring lost vertebral body
    Correction of the local kyphosis
    Based on end user, the global kyphoplasty systems market has been segmented as,

    Hospitals
    Clinics
    Ambulatory Surgical Centers
    Based on geography, the global kyphoplasty systems market has been segmented as,

    North America
    Latin America
    Europe
    CIS & Russia
    Japan
    APEJ
    Middle East & Africa
    Kyphoplasty Systems Market: Overview

    According to a rheumatic report by Springer, a vertebral compression fracture is the most common injury among the elderly population with an incidence rate of about 700,000 per year in the United States itself and affects approximately 25 percent of all post-menopausal women in the U.S. Balloon Kyphoplasty Systems is expected to register significant growth in Kyphoplasty Systems market as the inflation of the balloon helps in restoring deformity height and maintains the deformity shape as well. This can further be attributed to the increasing prevalence of multiple myeloma, traumatic spinal injuries, spinal tumors, etc. Kyphoplasty systems take care of the long-term maintenance of spinal bones, which are injured by compression fractures. These kyphoplasty systems also provide pain relief, improve back function, provide quality of life and thus, are preferred over vertebroplasty systems.

    Request Customized Report As Per Your Requirements: 
    rnhttps://www.factmr.com/connectus/sample?flag=RC&rep_id=1499

    Kyphoplasty Systems Market: Regional Outlook

    The Europe kyphoplasty systems market, mainly Germany and Italy, is expected to grow with the fastest rate over the forecast period, owing to the continued adoption of better and expensive kyphoplasty systems. The Austria kyphoplasty systems market is also anticipated to register significant growth over the forecast period. The North America kyphoplasty systems market is estimated to witness remarkable growth over the forecast period, owing to the improved healthcare expenditure in the region. Several available reforms such as the Affordable Care Act in the U.S. have led to an increase in the adoption of kyphoplasty systems. Increase in morbidity among the elderly population with vertebral compression fracture is expected to drive the significant growth of the Asia-Pacific kyphoplasty systems market.

    Kyphoplasty Systems Market: Market Participants

    The major market participants operating in the global kyphoplasty systems market include Medtronic Plc, DePuy Synthes, Stryker Corp, CareFusion, Somatex, Zimmer Biomet, Cook Medical, AOI Medical, Bone Support, Taeyeon Medical Co. Ltd., Benvenue Medical, Joimax, DFine, Crosstrees Medical, Maxxspine, Joline, Tecres, SI-Bone, Zavation and Vexim. Companies operating in Kyphoplasty Systems market have introduced improved radiopaque markers to improve the visual efficiency of balloon positioning.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    The report covers exhaustive analysis on,

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies involved
    Technology
    Value Chain
    Regional analysis includes,

    North America
    U.S.
    Canada
    Latin America
    Brazil
    Mexico
    Argentina
    Chile
    Peru
    Rest of LATAM
    Europe
    EU – 4 (Germany, France, Italy, Spain)
    K.
    BENELUX (Belgium, Netherlands, Luxemburg)
    NORDIC (Norway, Denmark, Iceland, Sweden)
    Eastern Europe (Poland, Ukraine, Czech Rep., etc.)
    Rest of Europe
    CIS & Russia
    Japan
    APEJ
    Greater China
    India
    Korea
    ASEAN Countries
    Rest of APEJ
    Middle East & Africa
    GCC Countries
    Turkey
    Iran
    Israel
    South Africa
    Rest of MEA
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint
    For more information about this report visit https://www.factmr.com/report/1499/kyphoplasty-systems-market


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 07, 2018 ) Ostomy is a surgical procedure that includes stoma, an artificial opening and is made out of the colon of the human body to dispense body wastes such as mucus, stools and urine. As per the National Institute of Diabetes and Digestive and Kidney Diseases, ostomy can be classified into three types viz. colostomy, ileostomy and urostomy. Ostomy drainage systems include either plastic or rubber bags/pouches, which collect these wastes. Two types of ostomy drainage systems are available in the market, namely one-piece ostomy drainage systems and two-piece ostomy drainage systems. One-piece ostomy drainage systems include a skin barrier and collecting bag as one single unit, whereas two-piece ostomy drainage systems include both, a skin barrier and the collecting bag differently so that the collecting bag can be separated leaving the skin barrier as it is. According to a report by the University of North Carolina, increasing incidences in the United States for ostomy surgeries can be attributed to the increasing prevalence of colorectal cancer and diverticular disease. Increasing need for ostomy drainage systems in youth and adults for ostomy surgeries is also growing by the day.

    Ostomy Drainage Systems Market: Drivers

    Increasing prevalence of bladder cancer, colorectal cancer, inflammatory bowel disease, Crohn’s disease and urinary tract cancer, growing elderly population who require ostomy drainage systems, preference among the youth and adults for ostomy drainage systems in ostomy surgeries, improved reimbursement scenario for ostomy and increasing awareness regarding ostomy procedures are expected to be the major factors leading the growth of the Ostomy Drainage Systems Market over the period of forecast. On the other hand, other alternatives for this procedure in the market and the risk of complications such as sore skin, stoma retention, prolapsed stoma, parastomal hernia and food bolus blockage might hinder the ostomy drainage systems market growth over the forecast period.

    Get Experts' Insights For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=1498

    Ostomy Drainage Systems Market: Segmentation

    Tentatively, the global ostomy drainage systems market can be segmented on the basis of product type, type of use, end user and geography.

    On the basis of product type, the global ostomy drainage systems market has been segmented as,

    Colostomy Ostomy Drainage Systems
    Urostomy Ostomy Drainage Systems
    Ileostomy Ostomy Drainage Systems
    On the basis of type of use, the global ostomy drainage systems market has been segmented as,

    Multi-use Ostomy Drainage Systems
    Single-use Ostomy Drainage Systems
    On the basis of end user, the global ostomy drainage systems market has been segmented as,

    Healthcare
    Hospitals
    Clinics
    Patient Care Centers
    Homecare
    Ostomy Drainage Systems Market: Overview

    In an Ileostomy, the small intestine or the base of the ileum is connected to the stoma or opening. It is a surgical operation used to connect the colon, anus and rectum. A colostomy is when the colon is connected to the stoma, only bypassing the rectum and anus. A urostomy is when the pipes carrying urine are connected to the stoma helping in bypassing the bladder. The demand for colostomy drainage systems is growing due to the high increase in the number of colorectal cancer cases, which are caused due to diseases in the intestine, genetic disorders and side effects of the treatment. Healthcare facilities viz. hospitals, patient care centers and clinics are expected to hold major market shares in the ostomy drainage systems market over the homecare sector.

    Ostomy Drainage Systems Market: Regional Outlook

    The North America ostomy drainage market is expected to register remarkable growth, owing to the increase in patient awareness, growth in the elderly population, presence of many healthcare vendors and advanced healthcare facilities. The ostomy drainage systems market in Asia Pacific, mainly India and China, is also expected to project a high growth rate over the forecast period. Increase in the incidences of diseases is leading to an increase in the number of ostomy surgeries. Further, improved healthcare expenditure and favorable reimbursement policies by the government are projected to drive the market growth during the forecast period.

    Ostomy Drainage Systems Market: Market Participants

    The major market participants operating in the global ostomy drainage systems market include Hollister Incorporated, Salts Healthcare Limited, ConvaTech Inc., Welland Medical Limited, Coloplast A/S, Pelcin Healthcare Limited, B. Braun Melsungen AG, Attends Healthcare Products, Inc., Alcare Co. Limited, Flexicare Medical Limited, Cymed Ostomy Co. and Peak Medical Limited. Companies are focusing on technologically advancing Ostomy drainage systems by providing collection facilities for extended period of time.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    Request Customized Report As Per Your Requirements: 
    rnhttps://www.factmr.com/connectus/sample?flag=RC&rep_id=1498

    The report covers exhaustive analysis on:

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies involved
    Technology
    Value Chain
    Regional analysis includes

    North America
    U.S.
    Canada
    Latin America
    Brazil
    Mexico
    Argentina
    Chile
    Peru
    Rest of LATAM
    Europe
    EU – 4 (Germany, France, Italy, Spain)
    K.
    BENELUX (Belgium, Netherlands, Luxemburg)
    NORDIC (Norway, Denmark, Iceland, Sweden)
    Eastern Europe (Poland, Ukraine, Czech Rep., etc.)
    Rest of Europe
    CIS & Russia
    Japan
    APEJ
    Greater China
    India
    Korea
    ASEAN Countries
    Rest of APEJ
    Middle East & Africa
    GCC Countries
    Turkey
    Iran
    Israel
    South Africa
    Rest of MEA
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint
    For more information about this report visit https://www.factmr.com/report/1498/ostomy-drainage-systems-market


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 07, 2018 ) The hormone replacement therapy market is a fragmented landscape with presence of few tier one companies and upcoming players. Top five companies involved in the hormone replacement therapy formulations account for a significant the overall hormone replacement therapy market Share. Top 5 players – Novo Nordisk, Pfizer Inc., Janssen NV (a Johnson & Johnson company), Novartis AG and Bayer AG collectively – collectively account for 35 percent revenue share of the hormone replacement therapy market from on the global front.

    Request 100 Page Sample Report Now: https://www.factmr.com/connectus/sample?flag=S&rep_id=2224

    Tier 1 hormone replacement therapy companies are focused on carrying out clinical trials for new product development (NPD). Moreover, these companies are adopting vertical, horizontal and backward integration in a bid to achieve rapid expansion and pace in technological development.

    In addition, tier 1 hormone replacement therapy companies are forming alliances to co-develop and commercialize hormone replacement therapy drugs. For instance, Pfizer Inc., and Merck KGaA have formed a strategic alliance to develop avelumab (BAVENCIO) to manage hypothyroidism and other thyroid disorders.

    Agreement between FDA and NASEM to Impact Hormone Replacement Therapy Market Growth

    Food and Drug Administration (FDA) has signed an agreement with NASEM (National Academies of Science, Engineering & Medicine) and is carrying out expanded agreements with University of Maryland and Johns Hopkins University Centers for Regulatory Science and Innovation. Main focus behind this initiative was to conduct research and inform consumers regarding compounded drugs.

    NASEM is examining the utility of treating individuals with compounded BHRT (Bioidentical Hormone Replacement Therapy) products. Compounded Bioidentical hormone replacement therapy products such as testosterone and progesterone are used instead of FDA approved hormone replacement therapy drugs as BHRT drugs are considered more safe and natural for patients. This factor is likely to impact the clinical trials of new hormone replacement therapy products in turn challenging the growth of hormone replacement therapy market.

    Use of Low Cost Generic Versions of Hormone Replacement Therapy Drugs – An Upcoming Trend

    Affordability has always remained a major challenge for any pharmaceutical drug or formulation. Moreover, insufficient healthcare reimbursements have resulted in individuals opting for cheaper drugs with unclear drug effectiveness. This prompted manufactures of hormone replacement therapy drugs to produce generic versions of the formulations in a bid to bridge the gap between purchasing power of people and hormone replacement therapy drug pricing. Companies developing generic hormone replacement therapy drugs are also acquiring FDA approvals, which is direct inference apropos to drug effectiveness. For instance, Teva pharmaceuticals has introduced generic version of Estrace cream and estradiol vaginal cream in 2018. The trend is expected to auger well for the overall growth of the hormone replacement therapy market.

    Get Access To TOC Covering 200+ Topics: https://www.factmr.com/report/2224/hormone-replacement-therapy-market

    Hormone Replacement Therapy Associated with Reduced Dementia – Key Growth Propellant  

    Hormone replacement therapy can protect memory which is required to carry out short-term cognitive tasks after menopausal stress. Estrogen-only hormone replacement therapy can facilitate lower stress levels without impacting memory. In addition, hormone replacement therapy also reduces possibilities of both vascular dementia and Alzheimer’s disease.  

    Combination Hormone Replacement Therapy Associated with Cancer – Key Growth Deterrent

    Use of hormone replacement therapy can lead to cancerous cell development. The use of combination hormone replacement therapy (combination of progesterone and estrogen) can increase the risk of breast cancer by 75 percent even if used for a short timeframe. According to the U.S Women’s Health Initiative, the use of combination hormone replacement therapy comes with the risk of development of several cancers including ovarian and uterus cancers. This aspect is expected to confine the growth in adoption of hormone replacement therapy in the forthcoming years. Other hormone replacement therapy related disorders such as stroke, cardiac disorders and blood clots are further expected to negatively impact the growth of the hormone replacement therapy market.

    Competitive Landscape

    The report on hormone replacement therapy market offers intelligence on key participants in the hormone replacement therapy market. The key companies involved in the formulation of hormone replacement therapy products are thoroughly assessed and profiled in the report. Various facets of competition including SWOT analysis, product portfolio analysis, drug developments and innovations, strategies and key financials are covered. Key companies profiled in the report include Novartis AG, Novo Nordisk A/S, Teva Pharmaceuticals, Mylan N.V and Pfizer Inc.

    Ask Industry Expert about this Report: https://www.factmr.com/connectus/sample?flag=AE&rep_id=2224

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    Fact.MR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

older | 1 | .... | 1107 | 1108 | (Page 1109) | 1110 | 1111 | .... | 1118 | newer